antifungal drug discovery. In this report, the first-generation of small molecule SAP2 inhibitors was rationally designed and optimized using a structure-based approach. In particular, inhibitor 23h was highly potent and selective and showed good antifungal potency for the treatment of resistant Candida albicans infections.
靶向分泌的
天冬氨酸蛋白酶2(
SAP2),一种毒力因子,代表了抗真菌药物发现的新策略。在本报告中,使用基于结构的方法合理设计和优化了第一代小分子
SAP2
抑制剂。尤其是,
抑制剂23h具有很高的效力和选择性,并显示出良好的抗真菌效力,可用于治疗耐药性白色念珠菌感染。